The Central Government has banned the manufacture, sale, distribution, and supply of 16 fixed-dose combination (FDC) medicines across India with immediate effect. The decision was taken after an expert review found these drug combinations lacked therapeutic justification and posed potential health risks that outweighed their benefits. According to the Union Health Continue Reading
